Qube Research & Technologies LTD Capricor Therapeutics, Inc. Put Options Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CAPR
# of Institutions
68Shares Held
6.33MCall Options Held
210KPut Options Held
374K-
Black Rock Inc. New York, NY1.63MShares$8.13 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.55MShares$7.73 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA642KShares$3.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny480KShares$2.39 Million0.0% of portfolio
-
State Street Corp Boston, MA401KShares$2 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $121M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...